Evaluation of endovascular therapy of aorto-iliac lesions

• Conditions: I70.2; Atherosclerosis of arteries of extremities

• Registration Number: DRKS00032151
• Lead Sponsor: HZ Campus Bad Krozingen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-09-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Patients treated with abdominal aortic interventions or aortic interventions involving the iliac arteries or iliac arteries

Exclusion Criteria

Patients who were not treated aortally or aorto-iliacal

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acute intervention success, defined as <30% residual stenosis

Secondary Outcome Measures

Name	Time	Method
Freedom from target lesion revascularisation (TLR) at 12, 24, 36, 38 and 60 months.<br>Restenosis rate after 12, 24, 36, 38 and 60 months<br>Change in Rutherford-Becker classification at 12, 24, 36, 38 and 60 months<br>Amputation rate after 12, 24, 36, 38 and 60 months